DNAprint Genomics (DNAG)

[frogdreaming]

Ann, LOL

Please explain then, the status of the Biofrontera promise and the GMED promise. If I have erred in characterizing them as 'discarded' then perhaps you would enlighten us.

In regards to vague new directions, I am refering specifically to the Beth Israel deal. It has been suggested that 'sometime' in the future DNAP will develop and distribute a new version of an existing drug that has been started by Beth Israel. Given the lack of details involved and the complete lack of necessary financing, the direction can only be describes as vague, and that is giving it the benefit of the doubt.

I look forward to your response.

regards,
frog